Starpharma Holdings Limited announced that Mr. Justin Cahill commences in the role of Company Secretary 3 April 2023. Mr. Cahill has extensive corporate finance and leadership experience in the biopharmaceutical, food, and agricultural sectors for private and ASX-listed companies including CSL. To facilitate a smooth transition of company secretarial responsibilities Ms Tracy Weimar will continue as Joint Company Secretary for a handover period.

For the purposes of ASX Listing Rule 12.6, both Mr. Cahill and Ms Weimar are persons responsible for communications between the Company and ASX.